Imaging Diagnostic Systems, Inc.

Imaging company granted Canadian patent

Published in Telemedicine Week, June 1st, 2004

Imaging Diagnostic Systems, Inc., (IMDS) announced the international patent application filed April 1999 for "Laser Imaging Apparatus Using Biomedical Markers That Bind To Cancer Cells" was granted as Canadian patent No. 2,373,299 for a period of 20 years from the date of filing until April 1, 2019.

Robert Wake, vice president of engineering, stated, "This patent, the Canadian equivalent of U.S. Letters patent 5,952,664, broadly covers the optical imaging of fluorescent compounds. This will be extremely valuable in the future, as work by collaborators, such as Schering, AG, and others, results in developing cancer-specific fluorophores. Once these fluorophores are...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Telemedicine Week

Source: Telemedicine Week (2004-06-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry